RGT
Click for more information
1.79% 28.5¢ argent biopharma limited

In my humble opinion, MXC will first need time to sort out the...

  1. Ranghora
    746 Posts.
    clock Created with Sketch.
    27/04/16
    09:50
    Post #: 17605977
    In my humble opinion, MXC will first need time to sort out the purchase arrangements and then we will find out how much it costs and where the money is coming from.

    Considering there will most likely be a need for new capital, I am antecipating that there will be a requirement for either a CR or bank finance, hence I believe MXC will go into Suspension before it trades again.
    MXC Price at posting: 5.6¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
28.5¢ 		Change
0.005(1.79%) 		Mkt cap ! $13.79M
Open High Low Value Volume
28.5¢ 28.5¢ 28.5¢ $99 347

Buyers (Bids)

No. Vol. Price($)
2 14314 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 1000 1
View Market Depth
Last trade - 11.04am 26/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.